Home/Filings/4/0001437749-14-017696
4//SEC Filing

VIVEVE MEDICAL, INC. 4

Accession 0001437749-14-017696

CIK 0000879682operating

Filed

Sep 29, 8:00 PM ET

Accepted

Sep 30, 9:25 PM ET

Size

7.1 KB

Accession

0001437749-14-017696

Insider Transaction Report

Form 4
Period: 2014-09-23
Smith Brigitte
Director10% Owner
Transactions
  • Purchase

    Common Stock

    2014-09-23$0.53/sh+192,262$101,8993,791,069 total
  • Purchase

    Common Stock

    2014-09-23$0.53/sh+947,872$502,3723,598,807 total(indirect: See Footnotes)
Footnotes (5)
  • [F1]Directly beneficially owned by GBS BioVentures III.
  • [F2]GBS Venture Partners Limited is trustee for GBS BioVentures III and may be deemed to have sole voting and investment power over the shares beneficially owned by GBS BioVentures III. Brigitte Smith is the Managing Partner of GBS Venture Partners. Ms. Smith disclaims beneficial ownership of such shares except to the extent of her pecuniary interest therein
  • [F3]Such amount includes (a) 192,262 shares directly beneficially owned by Ms. Smith (see footnote 5) and (b) 3,598,807 shares indirectly beneficially owned by Ms. Smith (see footnotes 1 and 2).
  • [F4]Such amount includes shares issued upon conversion of a Viveve, Inc. convertible promissory note with an aggregate principal and interest amount of $85,716.55, at a conversion price of $0.53 per share.
  • [F5]Such amount includes shares issued upon conversion of a Viveve, Inc. convertible promissory note with an aggregate principal and interest amount of $101,898.63, at a conversion price of $0.53 per share

Issuer

VIVEVE MEDICAL, INC.

CIK 0000879682

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000879682

Filing Metadata

Form type
4
Filed
Sep 29, 8:00 PM ET
Accepted
Sep 30, 9:25 PM ET
Size
7.1 KB